Bruce Stouffer

588 total citations
22 papers, 253 citations indexed

About

Bruce Stouffer is a scholar working on Radiology, Nuclear Medicine and Imaging, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Bruce Stouffer has authored 22 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Oncology. Recurrent topics in Bruce Stouffer's work include Radiopharmaceutical Chemistry and Applications (5 papers), Biosimilars and Bioanalytical Methods (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Bruce Stouffer is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (5 papers), Biosimilars and Bioanalytical Methods (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). Bruce Stouffer collaborates with scholars based in United States, Germany and Sweden. Bruce Stouffer's co-authors include Xiaohui Xu, Mark E. Arnold, Jim X Shen, William Mylott, Michael Furlong, David W. Boulton, Laura Cojocaru, Michael W. Lago, Steve E. Unger and Lisa J. Christopher and has published in prestigious journals such as Analytical Chemistry, The Journal of Infectious Diseases and Journal of Pharmaceutical Sciences.

In The Last Decade

Bruce Stouffer

20 papers receiving 236 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce Stouffer United States 11 70 56 52 42 35 22 253
Jiang Ji China 9 56 0.8× 56 1.0× 23 0.4× 26 0.6× 25 0.7× 24 278
René Vos Netherlands 11 53 0.8× 24 0.4× 23 0.4× 33 0.8× 82 2.3× 16 334
William Mylott United States 13 168 2.4× 41 0.7× 29 0.6× 86 2.0× 30 0.9× 28 410
F. Marfil Switzerland 11 55 0.8× 81 1.4× 37 0.7× 45 1.1× 39 1.1× 16 354
Yoon‐Jee Chae South Korea 11 90 1.3× 29 0.5× 16 0.3× 74 1.8× 32 0.9× 48 311
Helen Gu United States 12 112 1.6× 23 0.4× 103 2.0× 117 2.8× 110 3.1× 19 507
C Vidal Germany 11 97 1.4× 17 0.3× 16 0.3× 38 0.9× 116 3.3× 16 463
Nigel Dallow United Kingdom 11 47 0.7× 13 0.2× 19 0.4× 30 0.7× 16 0.5× 15 511
Shinji Kobuchi Japan 13 122 1.7× 17 0.3× 57 1.1× 198 4.7× 61 1.7× 61 529

Countries citing papers authored by Bruce Stouffer

Since Specialization
Citations

This map shows the geographic impact of Bruce Stouffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Stouffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Stouffer more than expected).

Fields of papers citing papers by Bruce Stouffer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Stouffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Stouffer. The network helps show where Bruce Stouffer may publish in the future.

Co-authorship network of co-authors of Bruce Stouffer

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Stouffer. A scholar is included among the top collaborators of Bruce Stouffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Stouffer. Bruce Stouffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ji, Qin, Xiaohui Xu, Eric Ma, et al.. (2015). Selective Reaction Monitoring of Negative Electrospray Ionization Acetate Adduct Ions for the Bioanalysis of Dapagliflozin in Clinical Studies. Analytical Chemistry. 87(6). 3247–3254. 28 indexed citations
2.
Xu, Xiaohui, Anne Rose, Timothy Eley, et al.. (2014). Quantitative Determination of Free/Bound Atazanavir Via High-Throughput Equilibrium Dialysis and LC-MS/MS, and The Application in Ex Vivo Samples. Bioanalysis. 6(23). 3169–3182. 5 indexed citations
3.
Furlong, Michael, Bing He, William Mylott, et al.. (2012). A validated enantioselective LC–MS/MS assay for the simultaneous determination of carvedilol and its pharmacologically active 4′-hydroxyphenyl metabolite in human plasma: Application to a clinical pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 70. 574–579. 25 indexed citations
4.
5.
Barbosa, Maria D.F.S., Carol Gleason, Flora Berisha, et al.. (2012). Addressing drug effects on cut point determination for an anti-drug antibody assay. Journal of Immunological Methods. 384(1-2). 152–156. 4 indexed citations
6.
Xu, Xiaohui, Qin Ji, Mohammed Jemal, et al.. (2012). Fit-For-Purpose Bioanalytical Cross-Validation for LC–MS/MS Assays in Clinical Studies. Bioanalysis. 5(1). 83–90. 14 indexed citations
7.
8.
9.
Vachharajani, Nimish N., et al.. (2011). The effects of age and gender on the pharmacokinetics and pharmacodynamics in healthy subjects of the plasminogen activator, lanoteplase. British Journal of Clinical Pharmacology. 72(5). 775–786. 5 indexed citations
10.
11.
Kostis, John B., Randy Dockens, Udho Thadani, et al.. (2002). Comparison of Pharmacokinetics of Lanoteplase and Alteplase During Acute Myocardial Infarction. Clinical Pharmacokinetics. 41(6). 445–452. 11 indexed citations
12.
Stouffer, Bruce, et al.. (1999). Validation of an Elisa for the Quantitation of Lanoteplase, A Novel Plasminogen Activator. Journal of Immunoassay. 20(4). 237–252. 4 indexed citations
13.
Vachharajani, N., et al.. (1999). Pharmacokinetics (PK) and pharmacodynamics (PD) of lanoteplase in healthy subjects. Clinical Pharmacology & Therapeutics. 65(2). 180–180. 1 indexed citations
14.
Kaul, Sanjeev, et al.. (1996). Specific radioimmunoassays for the measurement of stavudine in human plasma and urine. Journal of Pharmaceutical and Biomedical Analysis. 15(2). 165–174. 16 indexed citations
15.
Jagoda, Elaine M., et al.. (1993). Radioimmunoassay for Hydroxyphosphinyl-3-hydroxybutanoic Acid (SQ 33,600), a Hypocholesterolemia Agent. Therapeutic Drug Monitoring. 15(3). 213–213. 3 indexed citations
16.
Ogan, Marc D., et al.. (1993). A Specific Radioimmunoassay for the Measurement of Gadoteridol, a Contrast Agent for Magnetic Resonance Imaging in Biological Fluids. Journal of Pharmaceutical Sciences. 82(5). 475–479. 6 indexed citations
17.
Jagoda, Elaine M., et al.. (1992). A Radioimmunoassay for the New Antiviral Agent 1-β-D-Arabinofuranosyl-E-5-(2-bromovinyl)uracil. Therapeutic Drug Monitoring. 14(6). 499–508.
18.
Soike, Kenneth F., Bruce Stouffer, James Mitroka, et al.. (1992). Oral Bioavailability and Anti-Simian Varicella Virus Efficacy of 1- -D-Arabinofuranosyl-E-5-(2-Bromovinyl)Uracil (BV-araU) in Monkeys. The Journal of Infectious Diseases. 165(4). 732–736. 9 indexed citations
19.
Brennan, John J., et al.. (1992). Radioimmunoassay for Ceronapril, a New Angiotensin-Converting Enzyme Inhibitor, and Its Application to a Pharmacokinetic Study in Healthy Male Volunteers. Therapeutic Drug Monitoring. 14(3). 209–219. 1 indexed citations
20.
Brennan, John J., et al.. (1990). A Radioimmunoassay for SQ 27,519, the Active Phosphinic Acid-Carboxylic Diacid of the Prodrug Fosinopril in Human Serum. Therapeutic Drug Monitoring. 12(4). 404–410. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiang Ji Breakdown of academic impact, for papers by René Vos Breakdown of academic impact, for papers by William Mylott Breakdown of academic impact, for papers by F. Marfil Breakdown of academic impact, for papers by Yoon‐Jee Chae Breakdown of academic impact, for papers by Helen Gu Breakdown of academic impact, for papers by C Vidal Breakdown of academic impact, for papers by Nigel Dallow Breakdown of academic impact, for papers by Shinji Kobuchi
Rankless by CCL
2026